Warning letter
Miramar Cosmetics, Inc. [ARCHIVED]: warning letter of Aug 18, 2011
FDA warning letter UCM271416 · Florida District Office
Key facts
| Reference number | UCM271416 |
|---|---|
| Company | Miramar Cosmetics, Inc. [ARCHIVED] |
| Subject | CGMP for Finished Pharmaceuticals/Misbranded/Adulterated |
| Issue date | Aug 18, 2011 |
| Posted date | Aug 18, 2011 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 201.66(b)(2), 201.15(c), 347, 211.113(a), 211.165(b), 201.66, 211.160(a), 211.188 |
| Country | 3 |
| Inspection city | Doral |
| Inspection ZIP | 33172 |
| Inspection start date | Feb 4, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: